Pyridorin in type 2 diabetic nephropathy

E J Lewis, Tom Greene, Samuel Spitalewiz, Samuel Blumenthal, Tomas Berl, Lawrence G Hunsicker, Marc A Pohl, Richard Rohde, Itamar Raz, Yair Yerushalmy, Yoram Yagil, Tommy Herskovits, Robert Charles Atkins, Anne Therese Reutens, David K Packham, Julia B Lewis

Research output: Contribution to journalArticleResearchpeer-review

94 Citations (Scopus)

Abstract

Pyridoxamine dihydrochloride (Pyridorin, NephroGenex) inhibits formation of advanced glycation end products and scavenges reactive oxygen species and toxic carbonyls, but whether these actions translate into renoprotective effects is unknown. In this double-blind, randomized, placebo-controlled trial, we randomly assigned 317 patients with proteinuric type 2 diabetic nephropathy to twice-daily placebo; Pyridorin, 150 mg twice daily; or Pyridorin, 300 mg twice daily, for 52 weeks. At baseline, the mean age ? SD was 63.9?9.5 years, and themean duration of diabetes was 17.6?8.5 years; themean serumcreatinine level was 2.?60.6 mg/dl, and the mean protein-to-creatinine ratio was 2973?1932 mg/g. Regarding the primary end point, a statistically significant change in serum creatinine from baseline to 52 weeks was not evident in either Pyridorin group compared with placebo. However, analysis of covariance suggested that the magnitude of the treatment effect differed by baseline renal function. Among patients in the lowest tertile of baseline serum creatinine concentration, treatment with Pyridorin associated with a lower average change in serum creatinine concentration at 52 weeks (0.28, 0.07, and 0.14 mg/dl for placebo, Pyridorin 150mg, and Pyridorin 300mg, respectively; P=0.05 for either Pyridorin dose versus placebo); there was no evidence of a significant treatment effect in the middle or upper tertiles. In conclusion, this trial failed to detect an effect of Pyridorin on the progression of serumcreatinine at 1 year, although it suggests that patients with less renal impairment might benefit. Copyright ? 2012 by the American Society of Nephrology.
Original languageEnglish
Pages (from-to)131 - 136
Number of pages6
JournalJournal of the American Society of Nephrology
Volume23
Issue number1
DOIs
Publication statusPublished - 2012

Cite this